Inventor · disambiguated record
Gwenaella Rescourio
Also filed as: RESCOURIO GWENAELLA · RESCOURIO GWENAELLA CHRISTINE
18 granted patents·8 pending applications·128 citations·filing 2011–2025
93Inventor score
Top patents by PatentIndex Score
26 records- 0198US9845305B2Treprostinil derivative compounds and methods of using sameCORSAIR PHARMA INC·Filed 2016·Granted Dec 19, 2017·20 cites·17 claims
- 0298US9505737B2Treprostinil derivative compounds and methods of using sameCORSAIR PHARMA INC·Filed 2014·Granted Nov 29, 2016·45 cites·9 claims
- 0397US9371264B2Treprostinil derivative compounds and methods of using sameCORSAIR PHARMA INC·Filed 2014·Granted Jun 21, 2016·41 cites·9 claims
- 0494US11958822B2Treprostinil derivative compounds and methods of using sameCORSAIR PHARMA INC·Filed 2022·Granted Apr 16, 2024·1 cites·17 claims
- 0594US11718617B2Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of useAMGEN INC·Filed 2022·Granted Aug 8, 2023·4 cites·30 claims
- 0694US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 0793US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 0893US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 0989US12365663B2Treprostinil derivative compounds and methods of using sameCORSAIR PHARMA INC·Filed 2024·Granted Jul 22, 2025·0 cites·17 claims
- 1082US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 1181US12319691B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 1279US8742134B27-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereofTHERON PHARMACEUTICALS INC·Filed 2012·Granted Jun 3, 2014·3 cites·34 claims
- 1375US8742131B27-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereofPFISTER JÜRG R·Filed 2011·Granted Jun 3, 2014·3 cites·14 claims
- 1474US2025122183A1Nitrogen-Linked Benzisoxazole Sulfonamide DerivativesPFIZER·Filed 2024·Application pending·0 cites
- 1574US2025388574A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 1672US2025188030A1Biphenyl and Phenylpyridine CompoundsPFIZER·Filed 2024·Application pending·0 cites
- 1771US12252489B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 1870US8426611B27-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereofPFISTER JUERG R·Filed 2011·Granted Apr 23, 2013·1 cites·23 claims
- 1967US2025206756A1InhibitorsPFIZER·Filed 2024·Application pending·0 cites
- 2066US2025276966A1Nitrogen-Linked Benzisoxazole Sulfonamide DerivativesPFIZER·Filed 2025·Application pending·0 cites
- 2162US9320731B27-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereofTHERON PHARMACEUTICALS INC·Filed 2014·Granted Apr 26, 2016·0 cites·20 claims
- 2261US2024109915A1Novel acc inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 2354US2016296497A17-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereofTHERON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2454US2023227442A1Heteroalkyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2021·Application pending·0 cites
- 2544US11274105B2Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonistsAMGEN INC·Filed 2019·Granted Mar 15, 2022·0 cites·15 claims
- 2644US10668067B2Pyridine sulfonamidesAMGEN INC·Filed 2017·Granted Jun 2, 2020·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Gwenaella Rescourio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →